UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000041971
Receipt No. R000047896
Scientific Title Examination of CD109 expression in head and neck cancer
Date of disclosure of the study information 2020/10/01
Last modified on 2020/10/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Examination of CD109 expression in head and neck cancer
Acronym Examination of CD109 expression in head and neck cancer
Scientific Title Examination of CD109 expression in head and neck cancer
Scientific Title:Acronym Examination of CD109 expression in head and neck cancer
Region
Japan

Condition
Condition Head and neck cancer
Classification by specialty
Oto-rhino-laryngology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To investigate whether CD109 can be a biomarker in predicting the prognosis of head and neck cancer
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Correlation between the presence or absence of CD109 expression and OS and PFS
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit

Not applicable
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Among patients treated for head and neck cancer at Kitasato University Hospital between January 1, 2008 and December 31, 2013, biopsy was performed at Kitasato University Hospital Pathology Department and Otolaryngology / Head and Neck Surgery Patients with preserved formalin-fixed paraffin-embedded specimens of tissue and surgically resected tissue
Key exclusion criteria None
Target sample size 500

Research contact person
Name of lead principal investigator
1st name Taku
Middle name
Last name Yamashita
Organization Kitasato University
Division name Otorhinolaryngology / Head and Neck Surgery
Zip code 252-0373
Address 1-15-1 Kitazato Minami-ku Sagamihara Kanagawa Japan
TEL 042-778-8111
Email tyamahns@kitasato-u.ac.jp

Public contact
Name of contact person
1st name Shohei
Middle name
Last name Tsutsumi
Organization Kitasato University
Division name Otorhinolaryngology / Head and Neck Surgery
Zip code 252-0373
Address Otorhinolaryngology / Head and Neck Surgery
TEL 042-778-8111
Homepage URL
Email dm18020@st.kitasato-u.ac.jp

Sponsor
Institute Kitasato University
Institute
Department

Funding Source
Organization Kitasato University
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kitasato University School of Medicine / Hospital Ethics Committee
Address 1-15-1 Kitazato Minami-ku Sagamihara Kanagawa Japan
Tel 042-778-81118273
Email rinri@med.kitasato-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 10 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2019 Year 01 Month 19 Day
Date of IRB
2019 Year 01 Month 19 Day
Anticipated trial start date
2019 Year 01 Month 19 Day
Last follow-up date
2022 Year 03 Month 31 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This study is a retrospective observational study. We will perform immunohistochemical staining using tissue specimens of patients stored at our hospital and collect information from medical records.

Management information
Registered date
2020 Year 10 Month 01 Day
Last modified on
2020 Year 10 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047896

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.